Cathepsin S is aberrantly overexpressed in human hepatocellular carcinoma

Molecular Medicine Reports

Volumn 2, Issue 5, 2009, Pages 713-718

  Xu, Jing ^a   Li, Dong ^a   Ke, Zhiyuan ^b   Liu, Ruiming ^a   Maubach, Gunter ^b   Zhuo, Lang ^b  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Cathepsin S; Hepatocellular carcinoma; Hepatocytes

Indexed keywords

ALPHA FETOPROTEIN; CATHEPSIN S; HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PORTAL VEIN THROMBOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR THROMBUS; TUMOR VOLUME; WESTERN BLOTTING;

HEPATITIS B VIRUS;

EID: 69249215318     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000161     Document Type: Article

References (15)

1. Petanceska S, Canoll P and Devi LA: Expression of rat cathepsin S in phagocytic cells. J Biol Chem 271: 4403-4409, 1996. (Pubitemid 26070548)
2. Reddy VY, Zhang QY and Weiss SJ: Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 92: 3849-3853, 1995.
3. Vasiljeva O, Reinheckel T, Peters C, et al: Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 13: 387-403, 2007. (Pubitemid 46477760)
4. Gocheva V, Zeng W, Ke D, et al: Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20: 543-556, 2006. (Pubitemid 43345321)
5. Wang B, Sun J, Kitamoto S, et al: Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281: 6020-6029, 2006. (Pubitemid 43847703)
6. Ryschich E, Lizdenis P, Ittrich C, et al: Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. Cancer Res 66: 198-211, 2006. (Pubitemid 43166026)
7. Kos J, Sekirnik A, Kopitar G, et al: Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis. Br J Cancer 85: 1193-1200, 2001. (Pubitemid 33052320)
8. Fernandez PL, Farre X, Nadal A, et al: Expression of cathepsins B and S in the progression of prostate carcinoma. Int J Cancer 95: 51-55, 2001. (Pubitemid 32118613)
9. Flannery T, Gibson D, Mirakhur M, et al: The clinical significance of cathepsin S expression in human astrocytomas. Am J Pathol 163: 175-182, 2003. (Pubitemid 36759602)
10. Chang W, Wu H, Yeh C, et al: Lysosomal cysteine proteinase cathepsin S as a potential target for anti-cancer therapy. J Cancer Mol 3: 5-14, 2007.
11. Herkel J, Jagemann B, Wiegard C, et al: MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocytes. Hepatology 37: 1079-1085, 2003. (Pubitemid 36538684)
12. Paroli L, Lee C and Rifkind AB: Identification of hepatocytes as the major locus of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1-related P450s, TCDDAA and TCDDAHH, in chick embryo liver. Drug Metab Dispos 22: 962-968, 1994.
13. Kitamura H, Kamon H, Sawa S, et al: IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 23: 491-502, 2005. (Pubitemid 41587889)
14. Tang Y, Kitisin K, Jogunoori W, et al: Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci USA 105: 2445-2450, 2008.
15. Cheng XW, Kuzuya M, Nakamura K, et al: Localization of cysteine protease, cathepsin S, to the surface of vascular smooth muscle cells by association with integrin alphanubeta3. Am J Pathol 168: 685-694, 2006. (Pubitemid 43271165)